Levonorgestrel 52mg Intrauterine Device placement without uterine sounding: A Feasibility study.

Jewel A Brown, Sheeva Yazdani, Nicole Economou, Holly A Rankin, Anne N Flynn, Mitchell D Creinin
{"title":"Levonorgestrel 52mg Intrauterine Device placement without uterine sounding: A Feasibility study.","authors":"Jewel A Brown, Sheeva Yazdani, Nicole Economou, Holly A Rankin, Anne N Flynn, Mitchell D Creinin","doi":"10.1016/j.contraception.2024.110722","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate feasibility of levonorgestrel 52mg intrauterine device (IUD) placement without uterine sounding.</p><p><strong>Study design: </strong>We performed a three-phase feasibility study from February 2023-May 2024. In phase one, participants had levonorgestrel 52mg IUD placement with sounding. In the experimental phases, placement occurred without sounding and with (phase two) or without (phase three) concurrent transabdominal sonography and participants had 3-month follow-up. We defined feasibility as successful IUD placement without uterine sounding based on ultrasound confirmation immediately following placement. We measured total instrumentation time from the sound or inserter touching the cervix to inserter removal. Participants reported maximal pain experienced using a 100-mm Visual Analogue Scale when the inserter was removed. Physicians rated procedures as easy, moderate, or difficult. We calculated a sample size of 30 per phase so that if there was one failed placement, the lower 95% confidence interval of the successful placement rate would be no less than 90.0%.</p><p><strong>Results: </strong>Successful placement without sounding occurred in 30(100%) participants in phase two and 28(93.3%) in phase three. Median instrumentation was longest in phase one (49.5 [IQR 42.3-55.0] seconds) compared to phases two (16.0 [IQR12.0-28.0] seconds, p<0.0001) and three (25.0 [IQR 18.5-32.2] seconds, p<0.0001). Participants' median placement pain was 21.0 (IQR 10.3-32.8) mm in phase one with no difference in phase two (25.5 [IQR 14.3-47.0] mm, p=0.35), but was higher in phase three (36.0 [IQR 22.8, 61.0] mm, p=0.01).Physicians rated IUD placement \"easy\" most often in phase two (n=29[96.7%]) compared to phases one (n=22[73.3%], p=0.03) or three (n=22[73.3%], p=0.03). Participants experienced one perforation and one expulsion, both in phase three.</p><p><strong>Conclusion: </strong>Levonorgestrel 52mg IUD placement without sounding is feasible with concurrent sonography. Placement without sounding results in shorter instrumentation time but does not decrease maximum placement pain.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.contraception.2024.110722","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate feasibility of levonorgestrel 52mg intrauterine device (IUD) placement without uterine sounding.

Study design: We performed a three-phase feasibility study from February 2023-May 2024. In phase one, participants had levonorgestrel 52mg IUD placement with sounding. In the experimental phases, placement occurred without sounding and with (phase two) or without (phase three) concurrent transabdominal sonography and participants had 3-month follow-up. We defined feasibility as successful IUD placement without uterine sounding based on ultrasound confirmation immediately following placement. We measured total instrumentation time from the sound or inserter touching the cervix to inserter removal. Participants reported maximal pain experienced using a 100-mm Visual Analogue Scale when the inserter was removed. Physicians rated procedures as easy, moderate, or difficult. We calculated a sample size of 30 per phase so that if there was one failed placement, the lower 95% confidence interval of the successful placement rate would be no less than 90.0%.

Results: Successful placement without sounding occurred in 30(100%) participants in phase two and 28(93.3%) in phase three. Median instrumentation was longest in phase one (49.5 [IQR 42.3-55.0] seconds) compared to phases two (16.0 [IQR12.0-28.0] seconds, p<0.0001) and three (25.0 [IQR 18.5-32.2] seconds, p<0.0001). Participants' median placement pain was 21.0 (IQR 10.3-32.8) mm in phase one with no difference in phase two (25.5 [IQR 14.3-47.0] mm, p=0.35), but was higher in phase three (36.0 [IQR 22.8, 61.0] mm, p=0.01).Physicians rated IUD placement "easy" most often in phase two (n=29[96.7%]) compared to phases one (n=22[73.3%], p=0.03) or three (n=22[73.3%], p=0.03). Participants experienced one perforation and one expulsion, both in phase three.

Conclusion: Levonorgestrel 52mg IUD placement without sounding is feasible with concurrent sonography. Placement without sounding results in shorter instrumentation time but does not decrease maximum placement pain.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无子宫探查的左炔诺孕酮 52 毫克宫内节育器放置:可行性研究。
研究目的评估在不进行子宫探查的情况下放置左炔诺孕酮 52 毫克宫内节育器(IUD)的可行性:研究设计:我们在 2023 年 2 月至 2024 年 5 月期间进行了三阶段可行性研究。在第一阶段,参与者放置了左炔诺孕酮 52 毫克宫内节育器,并进行了子宫探查。在实验阶段,放置宫内节育器时不进行探查,同时进行(第二阶段)或不进行(第三阶段)经腹超声检查,参与者接受 3 个月的随访。我们将放置宫内节育器的可行性定义为成功放置宫内节育器,并在放置后立即通过超声波确认无子宫探查。我们测量了从发出声音或插入器接触宫颈到取出插入器的总时间。参与者使用 100 毫米视觉模拟量表报告取出置入器时的最大疼痛感。医生将手术分为简单、中等或困难。我们计算了每个阶段 30 人的样本量,这样如果有一次置入失败,置入成功率的 95% 置信区间下限将不低于 90.0%:第二阶段有 30 人(100%)成功置入,第三阶段有 28 人(93.3%)成功置入。与第二阶段(16.0[IQR12.0-28.0]秒,pConclusion)相比,第一阶段的仪器置入中位时间最长(49.5[IQR42.3-55.0]秒):左炔诺孕酮 52 毫克宫内节育器置入术无需进行超声检查。无探头放置可缩短器械放置时间,但不会减少最大放置疼痛。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation. Modeling the impact of decreasing waiting period length for Medicaid sterilization: A multi-site cohort study. Ongoing contraceptive goals of patients who did not achieve desired postpartum permanent contraception prior to hospital discharge. The association of insertion methods on immediate postpartum intrauterine device expulsion rates: A retrospective cohort study. Society of Family Planning Research Practice Support: Strategies and considerations for addressing race and racism in quantitative family planning studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1